Current role
Biotechnology · Healthcare
Board Member
2026-02-24–present
Andrew Miller, Ph.D.
Board Member
Kyverna Therapeutics, Inc. (KYTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KYTX alertsAbout Andrew Miller, Ph.D.
Andrew Miller, Ph.D. is recorded as Board Member at Kyverna Therapeutics, Inc. (KYTX) since February 24, 2026. Kyverna Therapeutics, Inc. reported in an 8-K filed February 24, 2026 that Andrew Miller, Ph.D. was appointed Class III director, effective February 24, 2026. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyverna Therapeutics, Inc. includes Warner Biddle (CEO and Board Member), Christi Shaw (Chairman and Board Member), Greg Martini (CFO) and 7 others.
“On February 24, 2026, the board of directors (the “Board”) of Kyverna Therapeutics, Inc. (the “Company”) appointed Andrew Miller, Ph.D. as a Class III director of the Company, effective immediately.”
Affiliation history
-
Current
2026-02-24–present
Company network
Leadership on record at Kyverna Therapeutics, Inc.
- Warner Biddle CEO, Board Member
- Christi Shaw Chairman, Board Member
- Greg Martini CFO
- Gregory Martini CFO, Chief Accounting Officer
- Marc Grasso CFO
- Marc Grasso, M.D. CFO
- Mayo Pujols CTO
- Andrew Miller Board Member
- Beth Seidenberg Board Member
- Fred E. Cohen Board Member